Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antidepressant Drugs: MAOIs and Other Agents
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Management of Schizophrenia Spectrum Disorders in the Outpatient Setting: A Quality Improvement Project.
Electronic Nicotine Delivery Systems (ENDS): What Nurses Need to Know.
Related Experiment Video
Updated: Dec 13, 2025

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
Published on: February 6, 2021
Adherence to Clinical Practice Guidelines When Prescribing Second-Generation Antipsychotics.
1East Tennessee State University powerslg@etsu.edu.
Adherence to monitoring guidelines for second-generation antipsychotics (SGAs) was low, with less than 30% of patients receiving initial blood glucose and lipid tests. This indicates a need for improved mental health care quality and patient monitoring.
Area of Science:
- Psychiatry
- Clinical Pharmacy
- Public Health
Background:
- Second-generation antipsychotics (SGAs) are widely used for mental illness treatment.
- Established guidelines recommend regular monitoring for adverse effects of SGAs.
- Assessing adherence to these guidelines is crucial for ensuring quality patient care.
Purpose of the Study:
- To evaluate adherence to side effect monitoring guidelines for SGAs.
- To assess the quality of care for mental illness patients at a community mental health center.
- To determine monitoring rates approximately 10 years post-guideline publication.
Main Methods:
- Retrospective chart review at an urban community mental health center in the Southeast US.
- Analysis of adherence rates for fasting blood glucose (FBG) and fasting lipid profile (FLP) monitoring.
- Data collection at baseline, 3 months, and 1 year.
Main Results:
- Initial combined FBG and FLP collection was only 30%.
- Monitoring rates decreased to 20% at 3 months and 14% at 1 year.
- Significant gaps in guideline adherence were identified.
Conclusions:
- Current adherence to SGA side effect monitoring guidelines is suboptimal.
- There is a clear need for practice improvements in mental health centers.
- Enhanced monitoring is essential to improve the quality of care for patients on SGAs.

